Aspirin-triggered lipid mediators

Details for Australian Patent Application No. 2001238468 (hide)

Owner The Brigham and Women's Hospital, Inc.

Inventors Serhan, Charles N.; Clish, Clary B.

Agent Watermark

Pub. Number AU-B-2001238468

PCT Pub. Number WO01/60778

Priority 60/238,814 06.10.00 US; 60/183,078 16.02.00 US

Filing date 16 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 6 July 2006

International Classifications

C07C 59/00 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 59/58 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 69/732 (2006.01) Esters of carboxylic acids

Event Publications

6 July 2006 Application Accepted

  Published as AU-B-2001238468

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238469-Oral, nasal and pulmonary dosage formulations of copolymer 1

2001238467